California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.
Category: Audio
A Shortfall of ECMO Treatment Cost Lives During the Delta Surge
About 50% of the covid-19 patients who got the last-ditch life support treatment at Vanderbilt University Medical Center died. Researchers wanted to know what happened to the many patients they had to turn away because ECMO (extracorporeal membrane oxygenation) machines and the specialized staffers needed were in short supply. The grim answer: 90% of those turned away perished.